Quality of life (QOL) differentiation analysis in patients undergoing controlled ovarian stimulation (COS) with two different preparations of recombinant human follicle-stimulating hormone (r-hFSH).
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- September 1, 2003
has subject area
- 1103 Clinical Sciences (FoR)
- 1114 Paediatrics and Reproductive Medicine (FoR)
- 1117 Public Health and Health Services (FoR)
- Obstetrics & Reproductive Medicine (Science Metrix)
published in
- Fertility and Sterility Journal